Dynavax Technologies
DVAX
A$15.63
Share price
-0.44%
Change (1 day)
-8.92%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : A$0.63 Billion
According to Dynavax Technologies 's latest financial reports the company's total liabilities are A$0.63 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | A$0.62 B | 13.75% |
| 2023-12-31 | A$0.55 B | -7.47% |
| 2022-12-31 | A$0.59 B | -47.2% |
| 2021-12-31 | A$1.12 B | 194.11% |
| 2020-12-31 | A$0.38 B | -0.94% |
| 2019-12-31 | A$0.38 B | 84.32% |
| 2018-12-31 | A$0.20 B | 751.6% |
| 2017-12-31 | A$24.63 M | -13.27% |
| 2016-12-31 | A$28.41 M | -29.97% |
| 2015-12-31 | A$40.56 M | -12.18% |
| 2014-12-31 | A$46.19 M | 124.83% |
| 2013-12-31 | A$20.54 M | -14.33% |
| 2012-12-31 | A$23.98 M | -28.13% |
| 2011-12-31 | A$33.37 M | 5.49% |
| 2010-12-31 | A$31.63 M | -35.54% |
| 2009-12-31 | A$49.08 M | -53.5% |
| 2008-12-31 | A$0.10 B | 13.48% |
| 2007-12-31 | A$93.01 M | 207.84% |
| 2006-12-31 | A$30.21 M | 285.83% |
| 2005-12-31 | A$7.83 M | -55.99% |
| 2004-12-31 | A$17.79 M | -85.1% |
| 2003-12-31 | A$0.11 B | -23.4% |
| 2002-12-31 | A$0.15 B | 60.65% |
| 2001-12-31 | A$97.05 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Agenus
AGEN | A$0.79 B | 25.93% | 🇺🇸 USA |
 Biogen BIIB | A$16.90 B | 2,563.79% | 🇺🇸 USA |
 Merck MRK | A$102.01 B | 15,978.09% | 🇺🇸 USA |
 Gilead Sciences GILD | A$57.11 B | 8,901.73% | 🇺🇸 USA |
 AstraZeneca AZN | A$99.57 B | 15,592.54% | 🇬🇧 UK |
 GlaxoSmithKline GSK | A$93.07 B | 14,569.35% | 🇬🇧 UK |
 Pfizer PFE | A$179.49 B | 28,187.87% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | A$49.15 B | 7,646.27% | 🇮🇱 Israel |
 Amgen AMGN | A$127.15 B | 19,939.18% | 🇺🇸 USA |